Daqing Li

Daqing Li, M.D. 是宾夕法尼亚大学医院耳鼻咽喉头颈外科教授、住院医师诊所临床主任、基因与分子治疗实验室主任、国际访问医师项目主任及颞骨实验室主任。 ADSFAEQWER353423413434

基础与转化研究：耳鼻咽喉头颈外科中的载体开发与靶向基因递送，头颈癌分子治疗，内耳疾病分子治疗。

ADFASDFAF23RQ23R

耳科与神经耳科。

1. Abuzeid WM, Jiang X, Shi G, et al. Molecular Disruption of Rad50 Sensitizes Tumor Cells to Cisplatin-based Chemotherapy. J Clin Invest. 2009;119:1974-1985.
2. Figures MR, Wobb J, Araki K, et al. Head and Neck Squamous Cell Carcinoma Targeted Chemosensitization. Otolaryngol Head Neck Surg. 2009;141:177-183.
3. Khan K, Araki K, Wang D, et al. Head and neck cancer radiosensitization by the novel poly(ADP-ribose) polymerase inhibitor GPI-15427. Head Neck. 2010;32:381-391.
4. Paulson DP, Abuzeid W, Jiang H, et al. A novel controlled local drug delivery system for inner ear disease. Laryngoscope. 2008;118(4):706-711.
5. Araki K, Ahmad S, Li G, et al. Retinoblastoma RB94 enhances radiation treatment of head and neck squamous cell carcinoma. Clin Cancer Res. 2008;14(11):3514-3519.
6. Li D, Henley CM, O'Malley BW. Distortion Product Otoacoustic Emissions and Outer Hair Cell Defects in the hyt/hyt Mutant Mouse. Hear Res. 1999;138:65-72.
7. Moe CS, Li D, Linder T, et al. An Update on the Surgical Treatment of Temporal Bone Paraganglioma. Skull Base Surg. 1999;9:185-194.
8. Li D, Xiang M, Gan L, et al. Essential Role of POU-Domain Factor Brn-3c in Auditory and Vestibular Hair Cell Development. Proc Natl Acad Sci USA. 1997;94:9445-9450.
9. Li D, Schauble B, Moll C, et al. Intratemporal Facial Nerve Perineurioma. Laryngoscope. 1996;106:328-333.
10. Li D, Cao Y. Facial Nerve Dehiscence: A Report of 1465 Stapes Surgeries. Ann Otol Rhinol Laryngol. 1996;105:467-471.

地址：145 CRB, 415 Curie Blvd, Philadelphia, PA 19104 ADFASDFAF23RQ23R
电话：Office: 215-615-0854; Fax: 215-898-4469
Email: lidaqing@mail.med.upenn.edu

ADSFAEQWER353423413434

• Li D, Xiang M, Gan L, et al. Essential role of POU-domain factor Brn-3c in auditory and vestibular hair cell development. Proc Natl Acad Sci USA. 1997;94:9445-9450.
• Li D, Henley CM, O'Malley BW. Distortion product otoacoustic emissions and outer hair cell defects in the hyt/hyt mutant mouse. Hear Res. 1999;138:65-72.
• Abuzeid WM, Jiang X, Shi G, et al. Molecular disruption of Rad50 sensitizes tumor cells to cisplatin-based chemotherapy. J Clin Invest. 2009;119:1974-1985.
• Araki K, Ahmad S, Li G, et al. Retinoblastoma RB94 enhances radiation treatment of head and neck squamous cell carcinoma. Clin Cancer Res. 2008;14(11):3514-3519.
• Khan K, Araki K, Wang D, et al. Head and neck cancer radiosensitization by the novel poly(ADP-ribose) polymerase inhibitor GPI-15427. Head Neck. 2010;32:381-391.
• Paulson DP, Abuzeid W, Jiang H, et al. A novel controlled local drug delivery system for inner ear disease. Laryngoscope. 2008;118(4):706-711.
• Figures MR, Wobb J, Araki K, et al. Head and Neck Squamous Cell Carcinoma Targeted Chemosensitization. Otolaryngol Head Neck Surg. 2009;141:177-183.
• Moe CS, Li D, Linder T, et al. An Update on the Surgical Treatment of Temporal Bone Paraganglioma. Skull Base Surg. 1999;9:185-194.
• Li D, Schauble B, Moll C, et al. Intratemporal Facial Nerve Perineurioma. Laryngoscope. 1996;106:328-333.
• Li D, Cao Y. Facial Nerve Dehiscence: A Report of 1465 Stapes Surgeries. Ann Otol Rhinol Laryngol. 1996;105:467-471.
• 吴皓, 李华伟. 内耳基因治疗研究进展. 中华耳科学杂志. 2015;13(1):1-5.
• Chen ZY, Corey DP. Progress and prospects in gene therapy for inherited hearing loss. Curr Opin Otolaryngol Head Neck Surg. 2014;22(5):366-371.
• 李琦, 姜鸿, 邱建华. 头颈部鳞癌分子靶向治疗研究进展. 临床耳鼻咽喉头颈外科杂志. 2016;30(12):997-1001.
• Gutkind JS, Molinolo AA. The evolution of personalized head and neck cancer therapeutics. Cancer Discov. 2014;4(5):512-516.